May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Twelve Novel Mutations in the CHST6 Gene Result in Macular Corneal Dystrophy
Author Affiliations & Notes
  • P.L. Dighiero
    Ophtalmologie, CHU de Poitiers, Poitiers, France
  • P. Ellies
    Ophtalmologie, CHU Hôtel Dieu, Paris, France
  • G. Renard
    Ophtalmologie, CHU Hôtel Dieu, Paris, France
  • F. Niel
    Biochimie Génétique, CHU Cochin, Paris, France
  • J. Soria
    Biochimie, CHU Hôtel Dieu, Paris, France
  • M. Delpech
    Biochimie, CHU Hôtel Dieu, Paris, France
  • S. Valleix
    Biochimie, CHU Hôtel Dieu, Paris, France
  • Footnotes
    Commercial Relationships  P.L. Dighiero, None; P. Ellies, None; G. Renard, None; F. Niel, None; J. Soria, None; M. Delpech, None; S. Valleix, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3860. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P.L. Dighiero, P. Ellies, G. Renard, F. Niel, J. Soria, M. Delpech, S. Valleix; Twelve Novel Mutations in the CHST6 Gene Result in Macular Corneal Dystrophy . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3860.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Identification of mutations in the CHST6 gene in fifteen patients from eleven unrelated families affected with recessive macular corneal dystrophy. Methods: Genomic DNA was extracted from peripheral blood leukocytes of the affected patients and their healthy family members, and the mutational status of the CHST6 gene was determined for each patient by a PCR-sequencing approach. Serum concentrations of antigenic keratan sulfate for each proband were determined by ELISA. Results: ELISA indicated that all affected patients, except one, were of MCD type I or IA. Fourteen distinct mutations were identified within the CHST6 coding region : 2 nonsense, 2 frameshift, and 10 missense mutations. Of these, 12 were novel and a nonsense mutation in the homozygous state is reported for the first time. Conclusions: These molecular results in French MCD patients combined with those reported from previous studies indicated CHST6 mutational heterogeneity. The characterization, here, of nonsense mutations is in keeping with the fact that MCD results from loss of function of the CHST6 protein product.

Keywords: cornea: basic science • genetics • clinical (human) or epidemiologic studies: pre 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×